Asarfi Hospital Limited

As of June 30, 2026, Asarfi Hospital Limited carries a market capitalization of 4.49B, placing it among publicly traded companies globally. Its enterprise value stands at 4.95B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Asarfi Hospital Limited has 19.68M shares outstanding.

As of June 30, 2026, Asarfi Hospital Limited trades at a trailing price-to-earnings ratio of 25.20. The price-to-sales ratio is 2.44, and the price-to-book ratio stands at 4.40.

As of June 30, 2026, Asarfi Hospital Limited trades at an EV/EBITDA multiple of 13.70 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 2.70 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 20.25 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 4.95B versus a market cap of 4.49B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Asarfi Hospital Limited maintains a current ratio of 1.49, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 53.77, indicating elevated leverage, while an interest coverage ratio of 8.62 demonstrates adequate ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Asarfi Hospital Limited posted a return on equity (ROE) of 19.15, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 12.77 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 9.71, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 14.57, useful for judging operating efficiency across full business cycles. Inventory turnover of 14.23 indicates how many times Asarfi Hospital Limited sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Asarfi Hospital Limited recorded 58.97M in income tax expense. That works out to an effective tax rate of 24.88, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 237.04M, leaving 178.07M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Asarfi Hospital Limited's stock has gained approximately 23.11% over the past 52 weeks. The 50-day moving average sits at 199.34, while the 200-day moving average is 196.54.

Over the twelve months ended June 30, 2026, Asarfi Hospital Limited generated 1.84B in revenue and converted that into 178.07M in net income, yielding earnings per share of 9.05. EBITDA reached 361.53M, while operating income came in at 244.54M.

As of June 30, 2026, Asarfi Hospital Limited holds 81.78M in cash and equivalents against 547.96M in total debt, resulting in a net debt position of 466.18M. Total book value stands at 1.02B, with working capital of 254.66M providing operational flexibility.

Asarfi Hospital Limited produced 164.89M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -204.06M in capital expenditures, free cash flow totaled -39.17M - equivalent to -1.99 per share.

Over the twelve months ended June 30, 2026, Asarfi Hospital Limited posted a gross margin of 77.65, reflecting its pricing power and cost economics. The operating margin of 13.31 and net profit margin of 9.69 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -0.87: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -0.85, meaning Asarfi Hospital Limited raised more capital through share issuance and new debt than it returned via dividends and buybacks.